CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,705,600 | +41.9% | 280,000 | +75.0% | 1.40% | +65.4% |
| Q2 2023 | $5,428,800 | -15.8% | 160,000 | -4.1% | 0.85% | +19.8% |
| Q4 2021 | $6,444,000 | -8.4% | 166,766 | +28.0% | 0.71% | +19.8% |
| Q3 2021 | $7,037,000 | +55.0% | 130,330 | -40.8% | 0.59% | +69.8% |
| Q1 2021 | $4,539,000 | -56.6% | 220,320 | -63.1% | 0.35% | -62.5% |
| Q4 2020 | $10,463,000 | +90.7% | 597,198 | +61.4% | 0.93% | +72.4% |
| Q3 2020 | $5,487,000 | – | 370,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |